相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Qi Wen et al.
BONE MARROW TRANSPLANTATION (2019)
High numbers of CD163+tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
Hua Wang et al.
JOURNAL OF CANCER (2019)
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
Kyohei Nakamura et al.
CANCER CELL (2018)
Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression
Kyu-Seon Oh et al.
JOURNAL OF IMMUNOLOGY (2018)
Lenalidomide enhances MOR202-dependent macrophage -mediated effector functions via the vitamin D pathway
Leonhard Busch et al.
LEUKEMIA (2018)
Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
Qinjie Weng et al.
CELL DEATH & DISEASE (2018)
CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
Emma C. Fink et al.
BLOOD (2018)
The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
M. Qorraj et al.
LEUKEMIA (2017)
The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma
Katia Georgopoulos
GENES & DEVELOPMENT (2017)
Metabolic gatekeeper function of B-lymphoid transcription factors
Lai N. Chan et al.
NATURE (2017)
SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
Jun Chen et al.
NATURE (2017)
Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma
S. Panchabhai et al.
LEUKEMIA (2016)
Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia
C. Song et al.
LEUKEMIA (2016)
Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
Alejandra Gutierrez-Gonzalez et al.
BLOOD (2016)
High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
Hua Wang et al.
BRITISH JOURNAL OF CANCER (2016)
CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms
Alaa Amash et al.
JOURNAL OF IMMUNOLOGY (2016)
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
M. A. Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection
Ulrike Schleicher et al.
CELL REPORTS (2016)
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner et al.
BLOOD (2015)
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Guellue Goerguen et al.
CLINICAL CANCER RESEARCH (2015)
Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)
John P. Leonard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Marije B. Overdijk et al.
MABS (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Franz Kratochvill et al.
CELL REPORTS (2015)
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
Jeffrey Lee Jensen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study
Paul G. Richardson et al.
LANCET HAEMATOLOGY (2015)
Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation
Tomomi Toubai et al.
ONCOIMMUNOLOGY (2015)
Targeting the bone marrow microenvironment in multiple myeloma
Yawara Kawano et al.
IMMUNOLOGICAL REVIEWS (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function
Carissa Dege et al.
IMMUNOLOGICAL REVIEWS (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells
Venkateswara R. Simhadri et al.
BLOOD (2012)
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
Jaehyup Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
D. Kim et al.
LEUKEMIA (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response
Antonia Lopez-Girona et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Thomas Krausgruber et al.
NATURE IMMUNOLOGY (2011)
Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
Wenlong Hu et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Awakening lineage potential by Ikaros-mediated transcriptional priming
Toshimi Yoshida et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
Takashi Satoh et al.
NATURE IMMUNOLOGY (2010)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Genome-wide Lineage-Specific Transcriptional Networks Underscore Ikaros-Dependent Lymphoid Priming in Hematopoietic Stem Cells
Samuel Yao-Ming Ng et al.
IMMUNITY (2009)
M2 Macrophages phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
Marzia Leidi et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
Jian-Wen Han et al.
NATURE GENETICS (2009)
Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells
Sanmay Bandyopadhyay et al.
BLOOD (2007)
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression
Fernando O. Martinez et al.
JOURNAL OF IMMUNOLOGY (2006)
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
J Moreaux et al.
BLOOD (2004)
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria
FAW Verreck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
